
Diabetes Dialogue: Updates in Diabetes Management at ADCES, with Jennifer Clements, PharmD
The
During her time at the meeting, Clements was the primary presenter for a trio of sessions focus on U-500 insulin in the inpatient setting, treatment and prevention strategies for hypoglycemia, and clinical implications for SGLT2 inhibitors in chronic kidney disease for patients with diabetes. Clements also participated in other roles, either as a co-presenter or moderator, on a pair of sessions related to mental health support and using virtual reality to educate about psychosocial issues in diabetes.
In this edition of
Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives is available in an audio-only format on

























































